Propranolol Extended-Release Capsules bulk supplier for pharma manufacturers

Propranolol Extended-Release Capsules 60 mg, 80 mg, 120 mg, 160 mg Suppliers & Bulk Manufacturers

Available Forms: Extended-Release Capsules

Available Strengths: 60 mg, 80 mg, 120 mg, 160 mg

Reference Brands: Inderal LA®

Propranolol is a non-selective beta-adrenergic blocker that inhibits β1 and β2 receptors, reducing heart rate, cardiac output, and blood pressure. It decreases sympathetic nervous system activity, making it effective for hypertension, angina pectoris, arrhythmias, migraine prophylaxis, and essential tremor. The extended-release (ER) capsules provide a steady release over 24 hours, improving compliance and maintaining consistent blood levels. Propranolol ER is also used off-label for performance anxiety and PTSD symptoms.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Propranolol Extended-Release (ER) capsules are FDA-approved in the U.S. for treating hypertension, angina pectoris, arrhythmias, migraine prophylaxis, and essential tremor. As a non-selective beta-blocker, it is subject to cardiovascular safety labeling, and extended-release formulations must meet modified-release and bioequivalence standards. U.S. regulations require GMP-compliant manufacturing, stability data, and ongoing pharmacovigilance. In the European Union, propranolol ER is authorized for similar indications under national approvals, with adherence to EMA guidance on beta-blockers. EU-specific requirements include Risk Management Plans (RMPs) and post-marketing surveillance. For dossier-ready Propranolol ER capsules, visit Pharmatradz.com.

Propranolol Extended-Release Capsules — third party manufacturing & bulk supply

Propranolol Extended-Release Capsules 60 mg, 80 mg, 120 mg, 160 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Propranolol Extended-Release Capsules is supplied as Extended-Release Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Propranolol Extended-Release Capsules listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Propranolol Extended-Release Capsules →

Back to Listing

Frequently Asked Questions

Propranolol Extended-Release Capsules is listed as Extended-Release Capsules in 60 mg, 80 mg, 120 mg, 160 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Propranolol Extended-Release Capsules is referenced against Inderal LA®. Reference brands are shown for identification only and remain the property of their respective trademark owners.